• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bronchoscopy and molecular diagnostic techniques to identify superimposed infections in COVID-19-associated ARDS: a case series from Ecuador during the second wave.

作者信息

Briones Claudett Killen Harold, Briones-Claudett Mónica H, Murillo Vasconez Roger, Benitez Sólis Jaime G, Briones Zamora Killen H, Freire Amado X, Barberan-Torres Pedro, Grunauer Michelle

机构信息

School of Medicine, Universidad Internacional del Ecuador (UIDE), Quito, Ecuador.

Intensive Care Unit, Ecuadorian Institute of Social Security (IESS), Babahoyo, Ecuador.

出版信息

Front Med (Lausanne). 2024 Oct 30;11:1409323. doi: 10.3389/fmed.2024.1409323. eCollection 2024.

DOI:10.3389/fmed.2024.1409323
PMID:39540054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11557464/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65bf/11557464/a9646ff2ecfc/fmed-11-1409323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65bf/11557464/596f84829c9d/fmed-11-1409323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65bf/11557464/a9646ff2ecfc/fmed-11-1409323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65bf/11557464/596f84829c9d/fmed-11-1409323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65bf/11557464/a9646ff2ecfc/fmed-11-1409323-g002.jpg

相似文献

1
Bronchoscopy and molecular diagnostic techniques to identify superimposed infections in COVID-19-associated ARDS: a case series from Ecuador during the second wave.用于识别新型冠状病毒肺炎相关急性呼吸窘迫综合征中叠加感染的支气管镜检查和分子诊断技术：来自厄瓜多尔第二波疫情期间的病例系列
Front Med (Lausanne). 2024 Oct 30;11:1409323. doi: 10.3389/fmed.2024.1409323. eCollection 2024.
2
Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study.COVID-19 相关 ARDS 的表面活性物质治疗：回顾性病例对照初步研究。
Respir Res. 2021 Jan 18;22(1):20. doi: 10.1186/s12931-020-01603-w.
3
Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting.厄瓜多尔资源有限背景下，非药物干预对 COVID-19 影响的病毒学证据。
Emerg Microbes Infect. 2023 Dec;12(2):2259001. doi: 10.1080/22221751.2023.2259001. Epub 2023 Sep 12.
4
Quantitative SARS-CoV-2 RT-PCR and Bronchoalveolar Cytokine Concentrations Redefine the COVID-19 Phenotypes in Critically Ill Patients.定量 SARS-CoV-2 RT-PCR 和支气管肺泡细胞因子浓度重新定义了危重症 COVID-19 患者的表型。
J Intensive Care Med. 2024 Jun;39(6):525-533. doi: 10.1177/08850666231217707. Epub 2024 Apr 17.
5
Respiratory Support Techniques for COVID-19-Related ARDS in a Sub-Saharan African Country: A Multicenter Observational Study.撒哈拉以南非洲国家 COVID-19 相关 ARDS 的呼吸支持技术：一项多中心观察性研究。
Chest. 2023 Aug;164(2):369-380. doi: 10.1016/j.chest.2023.01.039. Epub 2023 Feb 10.
6
Pediatric Microlaryngoscopy and Bronchoscopy in the COVID-19 Era.儿科喉显微镜和支气管镜检查在 COVID-19 时代。
JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):608-612. doi: 10.1001/jamaoto.2020.1191.
7
Can fiberoptic bronchoscopy be applied to critically ill patients treated with noninvasive ventilation for acute respiratory distress syndrome? Prospective observational study.纤维支气管镜检查能否应用于接受无创通气治疗的急性呼吸窘迫综合征重症患者？前瞻性观察性研究。
BMC Pulm Med. 2016 May 31;16(1):89. doi: 10.1186/s12890-016-0236-y.
8
RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic.兰德适宜性小组来确定英国关于急性呼吸窘迫综合征（ARDS）管理的指南以及在 COVID-19 大流行背景下的其他策略的适用性。
Thorax. 2022 Feb;77(2):129-135. doi: 10.1136/thoraxjnl-2021-216904. Epub 2021 May 27.
9
Bronchoscopy in children with COVID-19: A case series.儿童 COVID-19 患者的支气管镜检查：病例系列研究。
Pediatr Pulmonol. 2020 Oct;55(10):2816-2822. doi: 10.1002/ppul.25015. Epub 2020 Aug 13.
10
A multidisciplinary approach to prolonged extracorporeal membrane oxygenation for acute respiratory distress syndrome due to coronavirus 2019-case report.多学科方法治疗2019冠状病毒病所致急性呼吸窘迫综合征的延长体外膜肺氧合——病例报告
AME Case Rep. 2022 Jan 25;6:8. doi: 10.21037/acr-21-51. eCollection 2022.

本文引用的文献

1
Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting.厄瓜多尔资源有限背景下，非药物干预对 COVID-19 影响的病毒学证据。
Emerg Microbes Infect. 2023 Dec;12(2):2259001. doi: 10.1080/22221751.2023.2259001. Epub 2023 Sep 12.
2
Evaluation of Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus respiratory tract superinfections among patients with COVID-19 at a tertiary-care hospital in Tehran, Iran.评价伊朗德黑兰一家三级医院 COVID-19 患者中鲍曼不动杆菌、肺炎克雷伯菌和金黄色葡萄球菌呼吸道合并感染的情况。
Eur J Med Res. 2023 Sep 2;28(1):314. doi: 10.1186/s40001-023-01303-3.
3
A report on SARS-CoV-2 first wave in Ecuador: drug consumption dynamics.
厄瓜多尔新型冠状病毒肺炎第一波疫情报告：药物消费动态
Front Pharmacol. 2023 Jun 14;14:1197973. doi: 10.3389/fphar.2023.1197973. eCollection 2023.
4
The Assessment of Multiplex PCR in Identifying Bacterial Infections in Patients Hospitalized with SARS-CoV-2 Infection: A Systematic Review.多重PCR在识别新冠病毒感染住院患者细菌感染中的评估：一项系统评价
Antibiotics (Basel). 2023 Feb 24;12(3):465. doi: 10.3390/antibiotics12030465.
5
Activation of tuberculosis in recovered COVID-19 patients: a case report.新冠康复患者中结核病的激活：一例病例报告。
Ann Med Surg (Lond). 2023 Feb 1;85(2):280-283. doi: 10.1097/MS9.0000000000000188. eCollection 2023 Feb.
6
Antibiotics Use in COVID-19 Patients: A Systematic Literature Review.COVID-19患者的抗生素使用：一项系统文献综述
J Clin Med. 2022 Dec 4;11(23):7207. doi: 10.3390/jcm11237207.
7
The significant role of Carbapenems-resistant in mortality rate of patients with COVID-19.碳青霉烯类耐药在新型冠状病毒肺炎患者死亡率中的重要作用。
Vacunas. 2023 Jan-Mar;24(1):13-18. doi: 10.1016/j.vacun.2022.10.004. Epub 2022 Nov 1.
8
Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis.接种和未接种 COVID-19 疫苗患者的临床结局：基于人群的分析。
Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7705-7712. doi: 10.26355/eurrev_202210_30047.
9
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.托珠单抗与巴瑞替尼治疗 COVID-19 住院患者的疗效比较：一项开放标签、随机对照临床试验。
Clin Microbiol Infect. 2023 Mar;29(3):372-378. doi: 10.1016/j.cmi.2022.10.015. Epub 2022 Oct 20.
10
The Burden of Carbapenem-Resistant in ICU COVID-19 Patients: A Regional Experience.重症监护病房新冠肺炎患者中耐碳青霉烯类感染的负担：一项地区经验
J Clin Med. 2022 Sep 2;11(17):5208. doi: 10.3390/jcm11175208.